depressed mood disorder
Conditions
Interventions
The intervention will consist of 8 weekly 30-minute BA sessions delivered by a
trained mental health nurse (MHN) of the primary care practice.
Sponsors
Pro Persona
Eligibility
Age
18 Years to 99 Years
Inclusion criteria
Inclusion criteria: The main inclusion criterion is a PHQ-9 score >9.
Exclusion criteria
Exclusion criteria: Patients will be excluded from the trial in the case of I) severe mental illness, including bipolar disorder, obsessive-compulsive disorder, (history of) psychosis, severe drug- or alcohol dependence. II) high risk of suicide. III) drug and/or alcohol abuse or dependence, IV) prior psychotherapy received in the previous year. V) current treatment by a mental health specialist. VI) moderate to severe cognitive impairment (MoCA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Depression severity as assessed with the Quick Inventory of Depressive Symptomatology (Q-IDS) and Patient Health Questionnaire 9 (PHQ-9) and quality of life as assessed with the EuroQuol-5D (EQ-5D) during the 8-week treatment period and follow-up. | — |
Secondary
| Measure | Time frame |
|---|---|
| A secondary goal of the study is to explore several process measures, moderators and predictors of treatment outcome. 1. Psychopathology will be measured using the Brief symptom inventory-18 (BSI-18; [54, 55]). 2. To assess the behavioural limitations that patient experience in daily life, The World Health Organization Disability Assessment Schedule 2.0 (WHODAS, short version) will be used [57]. 3. To test baseline cognitive functioning the Montréal Cognitive Assessment scale (MoCA) can be used. 4. To measure active behaviour in both BA and TAU conditions the behavioural activation for depression scale (BADS) can be used. The BADS is a 25-item self-report instrument measuring behavioural activation [61]. 5. The expected influence of BA on physical activity of depressed participants can be objectively registered with an accelerometer (DYnaPort MoveMonitor). 6. To test the extent of depressive brooding, the Dutch translation of the brooding subscale of the RRS will be used [69, 70] T 7. The De Jong Gierveld short scales for emotional and social loneliness, a 6-item self-report measure can be used to test loneliness[74]. 8. To measure therapeutic alliance, the Session Rating Scale (SRS) is the instrument of choice. It consists of 4 visual scales and aims to measure the self reported therapeutic alliance by the patient [75]. 9. With the Digit Symbol substitution test (DSST) the degeneration or improvement of psychomotor performance will be measured[76]. To measure whether behavioural activation is effective regardless of the level of executive functioning, the Stroop-task will be used at baseline, at the end of treatment and in follow up measures[78]. 10. Positive expectations about the treatment are related to better treatment outcome for people with Major depressive disorder [79]. To asses this, the credibility & expectancy questionnaire can be used. 54. Derogatis, L.R., Brief symptom inventory 18. Minneapolis, MN: NCS Pearson, 2000. 55. | — |
Countries
Netherlands
Outcome results
None listed